App aims to boost motivation in schizophrenia patients

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: A participant will be eligible for entry into the study if all the following criteria are met: * Completed participation in NCT05838625 study within 7 days of the extension study Baseline Visit (Day 1). * Is the sole user of an iPhone with an iPhone operating system (iOS) 14 or greater or a smartphone with an Android operating system (OS) 10 or greater and is willing to download and use the specified Study App required by the protocol. * Is willing and able to receive SMS text messages and push messages on their smartphone. * It is the owner of, and has regular access to, an email address. * Has regular access to the Internet via cellular data plan and/or wi-fi. * Had stable housing during NCT05838625, with no anticipated housing changes during the duration of this study. Exclusion Criteria: A participant will not be eligible for study entry if any of the following criteria are met: * Has not completed the Week 16 Visit (Day 112) in the NCT05838625 study. * Has a positive urine drug screening or participant self-reports use of synthetic cathinones (bath salts), synthetic cannabinoids (K2, Spice), inhalants, amphetamines (including MDMA/ecstasy), phencyclidine (PCP), cocaine, opiates, benzodiazepines, barbiturates, hallucinogens, or parenteral drugs. Participants with a positive urine drug test and/or recreational use of THC will not be excluded from the study at the discretion of the investigator. Participants with a positive urine drug screen (UDS) or self-report who have a valid prescription for barbiturates, benzodiazepines, or opiates will not be excluded from the study at the discretion of the investigator. * Has suicidal ideation or behavior, as assessed by the C-SSRS: 1. Participants with a "yes" response to either Items 4 or 5 on the C-SSRS Suicidal Ideation Item during the NCT05838625 study. 2. Participants with a "yes" response on the C-SSRS Suicidal Behavior Items within the last 6 months (26 weeks) prior to or at the Baseline Visit * Participants who, in the opinion of the investigator, present a serious risk of suicide.